Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a prognostic model related to copper dependence in breast cancer by single-cell sequencing analysis. | Front Genet | 2022 | 36082002 | PubTator, text mining | PubMed |
| Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. | Int J Mol Sci | 2022 | 36077433 | PubTator, text mining | PubMed |
| Molecular mechanisms underlying some major common risk factors of stroke. | Heliyon | 2022 | 36060992 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| Transplantation of PSA-NCAM-Positive Neural Precursors from Human Embryonic Stem Cells Promotes Functional Recovery in an Animal Model of Spinal Cord Injury. | Tissue Eng Regen Med | 2022 | 36036887 | PubTator, text mining | PubMed |
| Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma. | Front Genet | 2022 | 36035134 | PubTator, text mining | PubMed |
| Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway. | Front Oncol | 2022 | 36033517 | PubTator, text mining | PubMed |
| Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. | Nat Commun | 2022 | 36028490 | PubTator, text mining | PubMed |
| Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance. | Cancer Sci | 2022 | 36018546 | PubTator, text mining | PubMed |
| Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme. | Eur Heart J | 2022 | 36017745 | PubTator, text mining | PubMed |
| Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. | Viruses | 2022 | 36016386 | PubTator, text mining | PubMed |
| Hair Growth Regulation by Fibroblast Growth Factor 12 (FGF12). | Int J Mol Sci | 2022 | 36012732 | PubTator, text mining | PubMed |
| Activation of cAMP Signaling in Response to α-Phellandrene Promotes Vascular Endothelial Growth Factor Levels and Proliferation in Human Dermal Papilla Cells. | Int J Mol Sci | 2022 | 36012223 | PubTator, text mining | PubMed |
| Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma. | Cells | 2022 | 36010627 | PubTator, text mining | PubMed |
| Neutrophils and Neutrophil Extracellular Traps in Cardiovascular Disease: An Overview and Potential Therapeutic Approaches. | Biomedicines | 2022 | 36009397 | PubTator, text mining | PubMed |
| The Transgene Expression of the Immature Form of the HCV Core Protein (C191) and the LncRNA MEG3 Increases Apoptosis in HepG2 Cells. | Curr Issues Mol Biol | 2022 | 36005145 | PubTator, text mining | PubMed |
| Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution. | Front Oncol | 2022 | 36003795 | PubTator, text mining | PubMed |
| Characteristics and mechanisms of resorption in lumbar disc herniation. | Arthritis Res Ther | 2022 | 35999644 | PubTator, text mining | PubMed |
| Serglycin-induced interleukin-1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts to promote tumour angiogenesis and growth. | Clin Transl Med | 2022 | 35994394 | PubTator, text mining | PubMed |
| Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. | Reprod Biol Endocrinol | 2022 | 35986324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=37